Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Oct 13, 2026

ALDX — Aldeyra Therapeutics, Inc. Dilution Risk Tracker

Track ALDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALDX — Get alerts when the score changes →

As of October 13, 2026, Aldeyra Therapeutics, Inc. (ALDX) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Aldeyra Therapeutics, Inc. has a market capitalization of $54.64M, 60.33M shares outstanding, 125 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.70 approaching $1 threshold
🔔 Track ALDX — Get forecast alerts →

Market Data

Market Cap$54.64M
Shares Outstanding60.33M
Float52.93M
Cash$86.00M
Debt$15.30M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding60.33MVerified float table or market cache
Public Float52.93MVerified float table or market cache
Market Cap$54.64MMarket data cache
Cash Runway27.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 4 3, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 8.2% shares (2026Q1 vs prior)
125 institutional holders · 43.55M shares
#1 Knoll Capital Management, LLC 5.48M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.73M shares
#3 BlackRock, Inc. 3.76M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.47M
Days to Cover3.0
% of Float6.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-03-30
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-20
4 INSIDER TRANSACTION 2026-03-19
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ALDX Dilution Snapshot

Aldeyra Therapeutics, Inc. (ALDX) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ALDX's DilutionScore is currently 26/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 23/100 (Low risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202626/100MEDIUM60 days
Jul 16 – Aug 13, 202623/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ALDX shares outstanding have increased 0.2% from 60.18M (Mar 2026) to 60.32M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 28, 202660.32M52.93M▲ 0.18%
May 26, 202660.32M52.83M▼ 0.10%
May 19, 202660.32M52.88M▲ 8.60%
May 11, 202660.32M48.70M▲ 0.23%
May 09, 202660.32M48.59M▲ 0.05%
Mar 23, 202660.18M48.56M▼ 0.15%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ALDX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ALDX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ALDX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ALDX
ALDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.